Digestive Diseases and Sciences

, Volume 55, Issue 9, pp 2624–2628

Prevalence of Vitamin D Deficiency in Chronic Liver Disease

Original Article

Abstract

Vitamin D deficiency has been associated with cholestatic liver disease such as primary biliary cirrhosis. Some studies have suggested that cirrhosis can predispose patients to development of osteoporosis because of altered calcium and vitamin D homeostasis. The aim of this study was to determine the prevalence of vitamin D deficiency in patients with chronic liver disease.

Methods

One hundred and eighteen consecutive patients (43 with hepatitis C cirrhosis, 57 with hepatitis C but no cirrhosis, 18 with nonhepatitis C-related cirrhosis) attending the University of Tennessee Hepatology Clinic had their 25-hydroxyvitamin D level measured. Severity of vitamin D deficiency was graded as mild (20–32 ng/ml), moderate (7–19 ng/ml) or severe (<7 ng/ml), normal being >32 ng/ml.

Results

Of patients, 109/118 (92.4%) had some degree of vitamin D deficiency. In the hepatitis C cirrhosis group, 16.3% (7/43) had mild, 48.8% (21/43) had moderate, and 30.2% (13/43) had severe vitamin D deficiency. In the hepatitis C noncirrhotic group, 22.8% (19/57) had mild, 52.6% (30/57) had moderate, and 14% (8/57) had severe vitamin D deficiency. In the nonhepatitis C-related cirrhosis group, 38.9% (7/18) had mild, 27.8% (5/18) had moderate, and 27.8% (5/18) had severe vitamin D deficiency. Severe vitamin D deficiency (<7 ng/ml) was more common among patients with cirrhosis compared with noncirrhotics (29.5% versus 14.1%, P value = 0.05). Female gender, African American race, and cirrhosis were independent predictors of severe vitamin D deficiency in chronic liver disease.

Conclusion

Vitamin D deficiency is universal (92%) among patients with chronic liver disease, and at least one-third of them suffer from severe vitamin D deficiency. African American females are at highest risk of vitamin D deficiency.

Keywords

Vitamin D deficiency Chronic liver disease Cirrhosis 

Abbreviations

BMI

Body mass index

CLD

Chronic liver disease

HCV

Hepatitis C virus

MMP

Matrix metalloproteinase

25(OH)D

25-hydroxyvitamin D

References

  1. 1.
    DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl):1689S–1696S.PubMedGoogle Scholar
  2. 2.
    Imawari M, Akanuma Y, Itakura H, Muto Y, Kosaka K, Goodman DS. The effects of diseases of the liver on serum 25 hydroxyvitamin D and on serum binding protein for vitamin D and its metabolites. J Lab Clin Med. 1979;93:171–180.PubMedGoogle Scholar
  3. 3.
    Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.CrossRefPubMedGoogle Scholar
  4. 4.
    Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res. 2008;23:143–150.CrossRefPubMedGoogle Scholar
  5. 5.
    Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005;35:290–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Tsuneoka K, Tameda Y, Takase K, et al. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 1996;31:669–678.CrossRefPubMedGoogle Scholar
  7. 7.
    Masuda S, Okano T, Osawa K, et al. Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo). 1989;35:225–234.Google Scholar
  8. 8.
    Bouillon R, Auwerx J, Dekeyser L, et al. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab. 1984;59:86–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Chen CC, Wang SS, Jeng FS, et al. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol. 1996;11:417–421.CrossRefPubMedGoogle Scholar
  10. 10.
    Hepner GW, Roginsky M, Moo HF. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976;21:527–532.CrossRefPubMedGoogle Scholar
  11. 11.
    Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol. 2001;16:1022–1027.CrossRefPubMedGoogle Scholar
  12. 12.
    Monegal A, Navasa M, Guanabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148–154.CrossRefPubMedGoogle Scholar
  13. 13.
    Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–687.CrossRefPubMedGoogle Scholar
  14. 14.
    Koli K, Keski-Oja J. 1alpha, 25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000;11:221–229.PubMedGoogle Scholar
  15. 15.
    Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787–796.CrossRefPubMedGoogle Scholar
  16. 16.
    Dobak J, Grzybowski J, Liu FT, et al. 1, 25-dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci. 1994;8:18–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Garcíade León Mdel C, Montfort I, Tello Montes E, et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp Mol Pathol. 2006;80(1):97–108. Epub 2005 Dec 5.PubMedGoogle Scholar
  18. 18.
    Hamada T, Fondevila C, Busuttil RW, Coito AJ. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology. 2008;47(1):186–198.CrossRefPubMedGoogle Scholar
  19. 19.
    Khandoga A, Kessler JS, Hanschen M, et al. Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J Leukoc Biol. 2006;79:1295–1305.CrossRefPubMedGoogle Scholar
  20. 20.
    Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol. 2007;5(4):513–520. Epub 2007 Jan 10.CrossRefPubMedGoogle Scholar
  21. 21.
    Mawer EB, Klass HJ, Warnes TW, et al. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond). 1985;69:561–570.Google Scholar
  22. 22.
    Caniggia A, Lore F, di Cairano G, et al. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27:815–824.CrossRefPubMedGoogle Scholar
  23. 23.
    Skinner RK, Sherlock S, Long RG, et al. 25-hydroxylation of vitamin D in primary biliary cirrhosis. Lancet. 1977;1:720–721.CrossRefPubMedGoogle Scholar
  24. 24.
    Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073–1090.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Internal MedicineUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.Division of Gastroenterology and HepatologyUniversity of Tennessee Health Science CenterMemphisTNUSA

Personalised recommendations